Literature DB >> 7773543

The inhibition of CYP enzymes in mouse and human liver by pilocarpine.

T Kimonen1, R O Juvonen, E Alhava, M Pasanen.   

Abstract

1. Pilocarpine is a cholinomimetic natural alkaloid. Its interactions with testosterone hydroxylations, coumarin 7-hydroxylase (COH), dimethylnitrosamine N-demethylase (DMNA), pentoxyresorufin O-dealkylase (PROD) and 7-ethoxyresorufin O-deethylase (EROD), which are indicative of the activities of cytochrome P4502A5 (CYP2A5) or 6, 2E1, 2B, 1A, were examined in mouse and human liver microsomes. 2. In mouse liver microsomes the IC50 values of pilocarpine were 6 microM for COH and testosterone 15 alpha-hydroxylase (T15 alpha OH) activities, 4 microM for PROD, approximately 100 microM for DMNA and testosterone 6 beta-hydroxylase (T6 beta OH) activities and > 1 mM for EROD activity. 3. In human liver microsomes, the IC50 value for COH was 6 microM and for DMNA 10 microM; T15 alpha OH and PROD activities were not detectable but T6 beta OH and testosterone 16 beta/2 beta-hydroxylase activities were moderately inhibited (IC50 70 microM). 4. These results suggest that pilocarpine has (i) a high affinity towards phenobarbitone-inducible CYP2A4/5 and CYP2B activities in mouse liver, (ii) a high affinity towards CYP2A6 in human liver microsomes and (iii) a moderate affinity towards CYP3A enzyme(s) in both microsomal preparations. 5. The low IC50 concentrations in vitro indicate potential metabolic interactions between pilocarpine and several P450 enzymes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773543      PMCID: PMC1510190          DOI: 10.1111/j.1476-5381.1995.tb13279.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

Review 1.  The molecular biology of cytochrome P450s.

Authors:  F J Gonzalez
Journal:  Pharmacol Rev       Date:  1988-12       Impact factor: 25.468

2.  Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1.

Authors:  C L Crespi; B W Penman; J A Leakey; M P Arlotto; A Stark; A Parkinson; T Turner; D T Steimel; K Rudo; R L Davies
Journal:  Carcinogenesis       Date:  1990-08       Impact factor: 4.944

3.  Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations.

Authors:  M Kitada; T Kamataki; K Itahashi; T Rikihisa; Y Kanakubo
Journal:  Biochem Pharmacol       Date:  1987-02-15       Impact factor: 5.858

4.  Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse.

Authors:  H Raunio; T Syngelmä; M Pasanen; R Juvonen; P Honkakoski; M A Kairaluoma; E Sotaniemi; M A Lang; O Pelkonen
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

5.  Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse.

Authors:  P Honkakoski; M A Lang
Journal:  Arch Biochem Biophys       Date:  1989-08-15       Impact factor: 4.013

6.  The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.

Authors:  R Lindberg; B Burkhart; T Ichikawa; M Negishi
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

7.  Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity.

Authors:  J S Miles; A W McLaren; L M Forrester; M J Glancey; M A Lang; C R Wolf
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

8.  Oxidation of quinidine by human liver cytochrome P-450.

Authors:  F P Guengerich; D Müller-Enoch; I A Blair
Journal:  Mol Pharmacol       Date:  1986-09       Impact factor: 4.436

9.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

Authors:  S Yamano; J Tatsuno; F J Gonzalez
Journal:  Biochemistry       Date:  1990-02-06       Impact factor: 3.162

10.  Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.

Authors:  M Negishi; R Lindberg; B Burkhart; T Ichikawa; P Honkakoski; M Lang
Journal:  Biochemistry       Date:  1989-05-16       Impact factor: 3.162

View more
  6 in total

Review 1.  Polymorphisms of CYP2A6 and its practical consequences.

Authors:  H Raunio; A Rautio; H Gullstén; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

2.  Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine.

Authors:  Natasha M DeVore; Kathleen M Meneely; Aaron G Bart; Eva S Stephens; Kevin P Battaile; Emily E Scott
Journal:  FEBS J       Date:  2011-11-25       Impact factor: 5.542

3.  Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.

Authors:  Y Li; N Y Li; E M Sellers
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

4.  Preferential inhibition of CYP1A enzymes in hepatic microsomes by mexiletine.

Authors:  H Konishi; K Morita; T Minouchi; A Yamaji
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.441

5.  Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.

Authors:  T Kinonen; M Pasanen; J Gynther; A Poso; T Järvinen; E Alhava; R O Juvonen
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

Review 6.  Variation in CYP2A6 Activity and Personalized Medicine.

Authors:  Julie-Anne Tanner; Rachel F Tyndale
Journal:  J Pers Med       Date:  2017-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.